Pregled po CROSBI profilu: Igor Aurer (CROSBI Profil: 13608, MBZ: 165536)

1.

Premužić, Vedran; Bašić-Kinda, Sandra; Radman, Ivo; Dujmović, Dino; Ilić, Ivana; Živković, Neno; Maleta, Lucija; Kralik, Marko; Dobrenić, Margareta; Galunić-Bilić, Lea et al.

Glomerular filtration rate is an independent prognostic factor in patients with B-large cell lymphoma // Medicine, 102 (2023), 20; 33675, 5 doi:10.1097/MD.0000000000033675 (međunarodna recenzija, članak, znanstveni)

Pristup cjelovitom tekstu rada doi

2.

(KroHem) Mitrović, Zdravko; Dujmović, Dino; Jakšić, Ozren; Bašić-Kinda, Sandra; Gaćina, Petar; Periša, Vlatka; Prka, Željko; Dreta, Barbara; Galušić Davor; Holik, Hrvoje et al.

Dose-adjusted EPOCH and rituximab (DA-EPOCH-R) in older patients with high-risk aggressive diffuse large B-cell lymphoma: A real-life multicenter study by the Croatian Cooperative Group for Hematologic diseases (KroHem) // European journal of haematology, 111 (2023), 13957, 7 doi:10.1111/ejh.13957 (međunarodna recenzija, članak, znanstveni)

Pristup cjelovitom tekstu rada doi

3.

Galunić Bilić, Lea; Šantek, Fedor; Grah, Josip Joachim; Bašić-Kinda, Sandra; Mandac Smoljanović, Inga; Ostojić Kolonić, Slobodanka; Mitrović, Zdravko; Vodanović, Marijo; Dujmović, Dino; Aurer, Igor

Efficacy and toxicity of infradiaphragmal radiotherapy fields in lymphoma patients: a single-centre experience // Radiologia medica, 128 (2023), 1615, 9 doi:10.1007/s11547-023-01615-8 (međunarodna recenzija, članak, znanstveni)

Pristup cjelovitom tekstu rada doi

4.

(EORTC Lymphoma Group) Fornecker, Luc-Matthieu; Lazarovici, Julien; Aurer, Igor; Casasnovas, René-Olivier; Gac, Anne-Claire; Bonnet, Christophe; Bouabdallah, Krimo; Feugier, Pierre; Specht, Lena; Molina, Lysiane et al.

Brentuximab Vedotin Plus AVD for First-Line Treatment of Early-Stage Unfavorable Hodgkin Lymphoma (BREACH): A Multicenter, Open-Label, Randomized, Phase II Trial // Journal of Clinical Oncology, 41 (2023), 2; 327-335 doi:10.1200/jco.21.01281 (međunarodna recenzija, članak, znanstveni)

Pristup cjelovitom tekstu rada doi

5.

Vibor Milunović, Ida Hude, Goran Rinčić, Davor Galušić, Aron Grubešić, Marko Martinović, Nika Popović, Sunčana Divošević, Klara Brčić, Marin Međugorac, Luka Kužat, Dejan Strahija, Stefan Mrđenović, Inga Mandac Smoljanović, Delfa Radić- Krišto, Slavko Gašparov, Igor Aurer, Slobodanka Ostojić Kolonić

Clinical Dilemmas in the Treatment of Elderly Patients Suffering from Hodgkin Lymphoma // Biomedicines, 10 (2022), 1-22 doi:10.3390/biomedicines10112917. (međunarodna recenzija, pregledni rad, znanstveni)

doi

6.

Batinić, Josip; Vodanović, Marijo; Rončević, Pavle; Aurer, Igor

Hematologija // Primjeri u kliničkoj medicini / Premužić, Vedran (ur.).
Zagreb: Alfa, 2022. str. 55-73

7.

Liker, Milica; Bašić Kinda, Sandra; Duraković, Nadira; Bojanić, Ines; Aurer, Igor; Golubić Ćepulić, Branka

The appropriateness of platelet transfusions in hematological patients and the potential for improvement // Transfusion Clinique et Biologique, 31 (2022), 1246-7820, 7 doi:10.1016/j.tracli.2022.11.007 (međunarodna recenzija, članak, znanstveni)

Pristup cjelovitom tekstu rada doi pubmed.ncbi.nlm.nih.gov

8.

(EORTC Lymphoma Group) Fiaccadori, Valeria; Neven, Anouk; Fortpied, Catherine; Aurer, Igor; Andre, Marc; Federico, Massimo; Counsell, Nicholas; Phillips, Elizabeth H.; Clifton‐Hadley, Laura; Barrington, Sally F. et al.

Relapse patterns in early‐PET negative, limited‐ stage Hodgkin lymphoma (HL) after ABVD with or without radiotherapy–a joint analysis of EORTC/LYSA/FIL H10 and NCRI RAPID trials // British Journal of Haematology, 200 (2022), 18594, 9 doi:10.1111/bjh.18594 (međunarodna recenzija, članak, znanstveni)

doi

9.

(KroHem) Sertić, Zrinka; Lucijanić, Marko; Bašić-Kinda, Sandra; Serventi Seiwerth, Ranka; Periša, Vlatka; Sertić, Dubravka; Coha, Božena; Pulanić, Dražen; Perić, Zinaida; Desnica, Lana et al.

Non-Myelofibrosis Chronic Myeloproliferative Neoplasm Patients Show Better Seroconversion Rates after SARS-CoV-2 Vaccination Compared to Other Hematologic Diseases: A Multicentric Prospective Study of KroHem // Biomedicines, 10 (2022), 11; 2892, 11 doi:10.3390/biomedicines10112892 (međunarodna recenzija, članak, znanstveni)

Pristup cjelovitom tekstu rada doi

10.

Horgan, Denis; Walewski, Jan; Aurer, Igor; Visco, Carlo; Giné, Eva; Fetica, Bogdan; Jerkeman, Mats; Kozarić, Marta; da Silva, Maria Gomes; Dreyling, Martin

Tackling Mantle Cell Lymphoma in Europe // Healthcare, 10 (2022), 9; 1682, 15 doi:10.3390/healthcare10091682 (međunarodna recenzija, članak, znanstveni)

Pristup cjelovitom tekstu rada doi

11.

Dreyling, Martin; André, Marc; Gökbuget, Nicola; Tilly, Hervé; Jerkeman, Mats; Gribben, John; Ferreri, Andrés; Morel, Pierre; Stilgenbauer, Stephan; Fox, Christopher et al.

The EHA Research Roadmap: Malignant Lymphoid Diseases // HemaSphere, 6 (2022), 6; e726, 18 doi:10.1097/hs9.0000000000000726 (međunarodna recenzija, članak, znanstveni)

Pristup cjelovitom tekstu rada doi

12.

Hude Dragičević, Ida; Bašić-Kinda, Sandra; Dujmović, Dino; Radman, Ivo; Dreta, Barbara; Dotlić, Sandra; Galunić- Bilić, Lea; Dobrenić, Margareta; Kralik, Marko; Rončević, Pavle; Aurer, Igor

Reduced steroid exposure is safe and does not reduce disease control among Hodgkin lymphoma patients treated with escalated BEACOPP (eBEACOPP) // The 12th International Symposium on Hodgkin Lymphoma Abstract Book, HemaSPhere 6(S5)
Köln, Njemačka, 2022. str. 8-9 (poster, međunarodna recenzija, sažetak, znanstveni)

journals.lww.com

13.

Milunović, Vibor; Hude, Ida; Rinčić, Goran; Galušić, Davor; Grubešić, Aron; Martinović, Marko; Popović, Nika; Divošević, Sunčana; Brčić, Klara; Međugorac, Marin et al.

Clinical Dilemmas in the Treatment of Elderly Patients Suffering from Hodgkin Lymphoma: A Review // Biomedicines, 10 (2022), 11; 2917, 22 doi:10.3390/biomedicines10112917 (međunarodna recenzija, pregledni rad, znanstveni)

Pristup cjelovitom tekstu rada doi www.ncbi.nlm.nih.gov

14.

Galušić, Davor; Bašić-Kinda, Sandra; Pijuk, Anđela; Milunović, Vibor; Dreta, Barbara; Franjić, Neven; Coha, Božena; Sinčić-Petričević, Jasminka; Gaćina, Petar; Pejša, Vlatko et al.

Efficacy and Safety of Obinutuzumab-chemotherapy Combinations in Front-line Treatment of Follicular Non-Hodgkin Lymphoma During the COVID-19 Pandemic: A Study of KROHEM, the Croatian Cooperative Group for Hematologic Diseases // HemaSphere, 6 (2022), 12; e807, 6 doi:10.1097/HS9.0000000000000807 (međunarodna recenzija, članak, znanstveni)

doi journals.lww.com

15.

Lalić, Hrvoje; Aurer, Igor; Batinić, Drago; Višnjić, Dora; Smoljo, Tomislav; Babić, Antonija

Bendamustine: a review of pharmacology, clinical use and immunological effects (Review) // Oncology Reports, 47 (2022), 6; 114, 16 doi:10.3892/or.2022.8325 (međunarodna recenzija, pregledni rad, znanstveni)

Pristup cjelovitom tekstu rada doi www.spandidos-publications.com

16.

Batinić J, Radić Krišto D, Blaslov V, Jakić Bubalo M, Ivić M, Piršić M, Deak D, Rinčić G, Periša V, Sinčić Petričević J, Holik H, Vučinić Ljubičić I, Morić Perić M, Zekanović I, Krečak I, Berneš P, Romić I, Kužat L, Valković T, Dujmović D, Bašić- Kinda S, I Aurer

Daratumumab in treatment of relapsed/refractory multiple myeloma – experiences of the Croatian cooperative group for hematologic diseases (KROHEM) // EHA 2021
online;, 2021. (poster, međunarodna recenzija, ostalo, stručni)

17.

Aurer, Igor

Limfomi i upalne bolesti crijeva // Upalne bolesti crijeva / Vucelić, Boris (ur.).
Zagreb: Medicinska naklada, 2021. str. 654-659

Pristup cjelovitom tekstu rada

18.

Aurer, Igor

Dose adjusted R-EPOCH and other etoposide- containing regimens in first-line treatment of diffuse large B-cell lymphoma // Acta haematologica polonica, 52 (2021), 4; 325-328 doi:10.5603/AHP.2021.0062 (međunarodna recenzija, pregledni rad, znanstveni)

Pristup cjelovitom tekstu rada doi

19.

Sertić, Zrinka; Lucijanić, Marko; Bašić-Kinda, Sandra; Serventi Seiwerth, Ranka; Periša, Vlatka; Sertić, Dubravka; Coha, Bozena; Pulanić, Dražen; Šegulja, Dragana; Rogić, Dunja et al.

Serologic responses following Sars-Cov-2 vaccination and factors influencing it in patients with hematological malignant and non-malignant diseases - a prospective multicentric study // Blood, 138 (2021), Suppl 1
Atlanta (GA), Sjedinjene Američke Države, 2021. str. 47-49 doi:10.1182/blood-2021-153573 (poster, međunarodna recenzija, prošireni sažetak, znanstveni)

doi

20.

Duraković, Nadira; Perić, Zinaida; Bašić-Kinda, Sandra; Desnica, Lana; Dujmović, Dino; Radman Livaja, Ivo; Serventi- Seiwerth, Ranka; Aurer, Igor; Vrhovac, Radovan

The impact of achieving complete remission prior to allogeneic stem cell transplantation on progression-free survival in Hodgkin lymphoma // Clinical hematology international, 3 (2021), 116-118 doi:10.2991/chi.k.210704.002 (međunarodna recenzija, članak, stručni)

doi

21.

Popović, Nika; Mravak Stipetić, Marinka; Lelas, Antonela; Pulanić, Dražen; Radić Krišto, Delfa; Aurer, Igor; Valković, Toni

Prevencija i liječenje mukozitisa u bolesnika sa zloćudnim hematološkim bolestima: pregled područja i stav Hrvatske kooperativne grupe za hematološke bolesti (KROHEM). // Medicina Fluminensis, 57 (2021), 4; 373-383 doi:10.21860/medflum2021_264893 (domaća recenzija, pregledni rad, znanstveni)

Pristup cjelovitom tekstu rada doi hrcak.srce.hr

22.

Bašić-Kinda, Sandra; Mišura Jakobac, Karla; Sinčić-Petričević, Jasminka; Deak, Dajana; Vodanović, Marijo; Jakić-Bubalo, Marinka; Mitrović, Zdravko; Grubešić, Aron; Dreta, Barbara; Županić Krmek, Dubravka et al.

Improvement in the outcomes of mantle cell lymphoma in the last decade: a real-life non internventional study of the Croatian Cooperative Group for Hematologic Diseases // Croatian medical journal, 62 (2021), 5; 455-463 doi:10.3325/cmj.2021.62.455-63 (međunarodna recenzija, članak, znanstveni)

Pristup cjelovitom tekstu rada doi hrcak.srce.hr

23.

Alonso-Álvarez, Sara; Manni, Martina; Montoto, Silvia; Sarkozy, Clémentine; Morschhauser, Franck; Wondergem, Marielle J.; Guarini, Attilio; Magnano, Laura; Alcoceba, Miguel; Chamuleau, Martine et al.

Primary refractory follicular lymphoma: a poor outcome entity with high risk of transformation to aggressive B cell lymphoma // European journal of cancer (1990), 157 (2021), 132-139 doi:10.1016/j.ejca.2021.08.005 (međunarodna recenzija, članak, znanstveni)

Pristup cjelovitom tekstu rada doi

24.

Dreyling, Martin; Aurer, Igor; Federico, Massimo; Jerkeman, Mats; Kersten, Marie Jose; Linton, Kim; Mey, Ulrich; Tilly, Herve; Buske, Christian

EHA/ESMO clinical practice guidelines for the management of malignant lymphoma: recommendations for the second phase of the COVID-19 pandemic // HemaSphere, 5 (2021), 2; e529-e531 doi:10.1097/HS9.0000000000000529 (međunarodna recenzija, pregledni rad, stručni)

doi

25.

Jakšić, Ozren; Bašić-Kinda, Sandra; Krečak, Ivan; Aurer, Igor

COVID-19 u hematoloških bolesnika – analiza Krohema (5/2021) // Bilten Krohema, 13 (2021), 2; 3-4 (podatak o recenziji nije dostupan, osvrt, ostalo)

www.krohem.hr